Showing results (1-10 of 1,330) with videos related to

Sort By:
Pageof 133
Chinese Medicine|September 1, 2020
What we already know about rhubarb: a comprehensive reviewHong Xiang, Jiaxin Zuo, Fangyue Guo, et al.
Cell Death Discovery|January 29, 2024
Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1Fangyue Guo, Xufeng Tao, Yu Wu, et al.
European Journal of Pharmacology|December 2, 2023
Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapyHao Yu, Yuying Cui, Fangyue Guo, et al.
Bioconjugate Chemistry|May 12, 2026
Lipid Nanoparticle-Based αHTRA1 mRNA Improves Pancreatic Ductal Adenocarcinoma Redox Microenvironment by Suppressing HTRA1/HIF-1 SignalingXinya Zhao, Xufeng Tao, Hong Xiang, et al.
Cell Death & Disease|June 22, 2026
Methyltransferase METTL1 regulates MSC mRNA stability via m7G modification in acute pancreatitisXufeng Tao, Xiaonan Zhang, Fangyue Guo, et al.
BMC Medicine|August 27, 2023
Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylasesQi Zhou, Xufeng Tao, Fangyue Guo, et al.
Frontiers in Immunology|April 10, 2025
Targeted inhibitors of S100A9 alleviate chronic pancreatitis by inhibiting M2 macrophage polarization via the TAOK3-JNK signaling pathwayXufeng Tao, Yu Wu, Fangyue Guo, et al.
Iscience|February 20, 2026
Targeted inhibition of M2 macrophages polarization via a PDC attenuates chronic pancreatitis through the PPARα pathwayXin Kong, Xufeng Tao, Hong Xiang, et al.
Frontiers in Oncology|September 16, 2021
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future PerspectivesYu Wu, Qi Zhou, Fangyue Guo, et al.
Oncology Reports|September 17, 2019
Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathwayQingkai Zhang, Fenglin Hu, Fangyue Guo, et al.
Pageof 133